About Medlinker
Medlinker is a company based in Chengdu (China) founded in 2014 by Wang Shirui. It operates as a On-Demand Services, AI-as-a-Service, and HealthTech. Medlinker has raised $841.52 million across 6 funding rounds from investors including Tencent, China Renaissance Group and Sino Biopharmaceutical. Medlinker offers products and services including Future Doctor App and MedGPT. Medlinker operates in a competitive market with competitors including Verily, Wellframe, Memora Health, MD Revolution and AllyAlign, among others.
- Headquarter Chengdu, China
- Founders Wang Shirui
- Stage Decacorn
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Chengdu Medcloud Technology Co., Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$841.52 M (USD)
in 6 rounds
-
Latest Funding Round
$514 M (USD), Series E
Dec 13, 2021
-
Investors
Tencent
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Medlinker
Medlinker offers a comprehensive portfolio of products and services, including Future Doctor App and MedGPT. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Online consultation platform connecting patients with expert doctors.
AI tool assisting doctors with diagnostic efficiency.
Funding Insights of Medlinker
Medlinker has successfully raised a total of $841.52M across 6 strategic funding rounds. The most recent funding activity was a Series E round of $514 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series E — $514.0M
- First Round First Round
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2021 | Amount | Series E - Medlinker | Valuation |
investors |
|
| Nov, 2020 | Amount | Series D - Medlinker | Valuation |
investors |
|
| Jun, 2018 | Amount | Series D - Medlinker | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Medlinker
Medlinker has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Tencent, China Renaissance Group and Sino Biopharmaceutical. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
M&A advisory, asset management firm, and private equity fund focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Private equity investments are managed by Yunfeng Capital in China.
|
Founded Year | Domain | Location | |
|
Generics for cardio-cerebral diseases and hepatitis are developed and manufactured.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Medlinker
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Medlinker
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Medlinker Comparisons
Competitors of Medlinker
Medlinker operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Verily, Wellframe, Memora Health, MD Revolution and AllyAlign, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based solutions for health management are provided.
|
|
| domain | founded_year | HQ Location |
Mobile and AI-based platform offering support to providers for better patient engagement
|
|
| domain | founded_year | HQ Location |
Mobile messaging platform is utilized for chronic disease management.
|
|
| domain | founded_year | HQ Location |
Predictive analytics SaaS platform for patient engagement is provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based platform for long-term care coordination is provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Medlinker
Frequently Asked Questions about Medlinker
When was Medlinker founded?
Medlinker was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is Medlinker located?
Medlinker is headquartered in Chengdu, China. It is registered at Chengdu, Sichuan, China.
Who is the current CEO of Medlinker?
Wang Shirui is the current CEO of Medlinker. They have also founded this company.
Is Medlinker a funded company?
Medlinker is a funded company, having raised a total of $841.52M across 6 funding rounds to date. The company's 1st funding round was a Series D of $151.07M, raised on Jun 01, 2015.
What does Medlinker do?
A digital health platform is operated by Medlinker, connecting patients with renowned doctors from top hospitals in China for free online consultations. Services are offered across 26 clinical disciplines and over 100 subspecialties, covering more than 30,000 diseases. AI tools like MedGPT are utilized to assist doctors in diagnostics, while ensuring all advice is reviewed by real clinicians. The platform is focused on making premium medical resources accessible, promoting rational medical practices, and avoiding over-treatment. Solutions are tailored for common ailments and select specialized conditions, supported by extensive medical data and clinical guidelines.
Who are the top competitors of Medlinker?
Medlinker's top competitors include Verily, Memora Health and Wellframe.
What products or services does Medlinker offer?
Medlinker offers Future Doctor App and MedGPT.
Who are Medlinker's investors?
Medlinker has 6 investors. Key investors include Tencent, China Renaissance Group, Sino Biopharmaceutical, HongShan, and China Electronic Corporation.
What is Medlinker's valuation?
The valuation of Medlinker is $25B as of Dec 2021.